Navigation Links
Biosim Pharmaceuticals, Manufacturers of Generic ACTHAR, to Participate at Biotech Showcase 2013
Date:1/3/2013

Seattle, Washington (PRWEB) January 03, 2013

Biosim Pharmaceuticals LLC (http://www.biosimllc.com) today announced it will be participating in the Biotech Showcase 2013 on January 7th-9th. The Biotech showcase, held alongside the JP Morgan 2013 Healthcare Conference in San Francisco, brings together biopharmaceutical executives from around the world into a collaborative learning environment.

Biosim Pharmaceuticals, LLC will be scheduling private one to one meetings with partners and interested companies throughout the conference regarding Biosim's flagship product, a generic ACTHAR gel. The brand H.P. ACTHAR gel is a highly purified corticotrophin gelatin depot formulation manufactured by Questcor Pharmaceuticals for the treatment of infantile spasms, multiple sclerosis, nephrotic syndrome and rheumatic disorders. Please contact bd(at)biosimllc(dot)com to schedule a meeting.

About BioSim Pharmaceuticals:
BioSim (biosimllc.com), a Seattle-based pharmaceutical company, focuses on building a portfolio of generic drugs for the orphan disease markets. BioSim consists of a team of highly capable individuals working together to implement both the near, and long-term objectives of advancing our pre-clinical and clinical development, all the way through late-stage development.

Read the full story at http://www.prweb.com/releases/2013/1/prweb10286464.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1

Related biology technology :

1. Daiichi Sankyo And Coherus BioSciences Establish Strategic Collaboration To Develop And Commercialize Biosimilar Candidates
2. Alliance for Safe Biologic Medicines Chairman Urges FDA to Ensure that Patient Safety is the Cornerstone of Biosimilar Pathway
3. Immune Deficiency Foundation Urges FDA To Exempt Immunoglobulin From Biosimilars Pathway
4. Despite Recession, Global Biosimilars Market Grew Over 40% 2010-2011, Set to Reach $3.6 Billion by 2016
5. Biosimilars: Global Markets
6. UBM Conferences Unveils Details for Upcoming Generics and Biosimilars Conference
7. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
8. Synergy Pharmaceuticals, Inc. Files Suit Against Ironwood Pharmaceuticals, Inc. and its Chief Scientific Officer and Senior VP of R&D, Dr. Mark G. Currie
9. Silence Therapeutics Partner, Quark Pharmaceuticals, Extends its Agreement With Pfizer to Develop one of Its Compounds Containing Silences AtuRNAi in a New Indication
10. Auxilium Pharmaceuticals, Inc. to Present at the Jefferies 2012 Global Healthcare Conference
11. Auxilium Pharmaceuticals, Inc. to Present At The JMP Securities 2012 Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/24/2019)... ... 24, 2019 , ... Drug resistance has been declared as one of the ... becoming one of the most serious concerns. Hong Kong cannot be spared from the ... (CA-MRSA), or a seven-fold of the figure in 2007 – the year the disease ...
(Date:9/24/2019)... ... September 24, 2019 , ... In the past three years, the National Science ... South Dakota School of Mines & Technology that expands human understanding of ... to form a slimy and yet strong layer which is commonly known as a ...
(Date:9/17/2019)... , ... September 17, 2019 , ... ... improve success in chronic diseases, announces today that the U.S. Patent and Trademark ... combinatorial genetic algorithm to rank drug class recommendations for hypertension treatment. , ...
(Date:9/17/2019)... ... 2019 , ... MyBioGate Global Healthcare Innovation Competition Boston Preliminary ... a forum organized by MyBioGate, Inc. and CUBIO Innovation Center that promotes and ... of evaluation, twelve companies out of over 200 applications were selected to compete ...
Breaking Biology Technology:
(Date:10/3/2019)... , ... October 01, 2019 , ... ... pouring and dispensing of chemicals, reagents, and medias and to be a more ... Bag is the culmination of years of experience and feedback from the original ...
(Date:9/30/2019)... ... September 30, 2019 , ... USDM Life Sciences , ... science organizations to accelerate innovation and maximize productivity, announces that David Blewitt will ... Just 30 days to 21 CFR Part 11 compliance with Box, When: Friday, ...
(Date:9/25/2019)... ... 25, 2019 , ... The esteemed dental implant specialists at ... for a variety of procedures, including single tooth replacement, new “teeth-in-a-day” immediately functioning ... implants offer patients permanent tooth replacement solutions that look and function very ...
Breaking Biology News(10 mins):